Browse Category

Expansion Plans News 11 October 2025 - 21 November 2025

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Share Price Update: Buy‑Back Acceleration and US$1.5 Billion US Expansion Shape Outlook on 21 November 2025

MELBOURNE / SYDNEY – 21 November 2025 – CSL Limited (ASX: CSL), the Australian biopharmaceutical giant and long‑time ASX 20 heavyweight, entered Friday’s trade with two dominant storylines: a fresh on‑market share buy‑back update lodged with the ASX this morning, and the market’s ongoing reaction to its recently announced US$1.5 billion investment program in US plasma‑derived therapy manufacturing.  Global Newsroom | CSL+3Australian Securities Exchange+3AFR Company Announcements+3 At the same time, the CSL share price remains deep in recovery mode after a brutal year. External research estimates the stock is down roughly 36% year to date, turning what was once a market darling into
21 November 2025
Crypto Exchange Sensation: CZR’s CoinMarketCap Debut, 25K Users & Bold Expansion Plans

Crypto Exchange Sensation: CZR’s CoinMarketCap Debut, 25K Users & Bold Expansion Plans

CZR Exchange’s Debut on CoinMarketCap – A New Era of Transparency CZR Exchange’s official CoinMarketCap listing (announced October 10, 2025) marks a pivotal step for the young platform apnews.com. CoinMarketCap (CMC) is one of the world’s most-referenced crypto data sites, so being listed there boosts CZR’s visibility and credibility globally. The listing provides investors and traders a transparent view of CZR Exchange’s markets – including real-time trading volumes, liquidity stats, and performance of trading pairs apnews.com. It effectively puts CZR on the map alongside more established exchanges. Importantly, CZR’s CMC page emphasizes transparency and accountability. “Transparency has always been at
Go toTop